|
市場調査レポート
商品コード
1746564
日本の組織診断市場レポート：製品タイプ、技術、疾患、エンドユーザー、地域別、2025年～2033年Japan Tissue Diagnostics Market Report by Product Type, Technology, Disease, End User, and Region 2025-2033 |
||||||
カスタマイズ可能
|
|||||||
| 日本の組織診断市場レポート：製品タイプ、技術、疾患、エンドユーザー、地域別、2025年～2033年 |
|
出版日: 2025年06月02日
発行: IMARC
ページ情報: 英文 122 Pages
納期: 5～7営業日
|
- 全表示
- 概要
- 目次
日本の組織診断市場規模は2024年に2億4,360万米ドルに達しました。今後、IMARC Groupは、同市場が2033年までに4億4,040万米ドルに達し、2025～2033年の成長率（CAGR）は6.3％になると予測しています。デジタル病理学、次世代シークエンシング（NGS）、高度なイメージング技術など、技術の進歩が進み、組織診断の精度と効率が向上したことが市場を牽引しています。
本レポートで扱う主な質問
- 日本の組織診断市場はこれまでどのように推移し、今後どのように推移していくのか？
- COVID-19が日本の組織診断市場に与えた影響は？
- 日本の組織診断市場の製品タイプ別区分は？
- 日本の組織診断市場の技術別区分は？
- 日本の組織診断市場の疾患別区分は？
- 日本の組織診断市場のエンドユーザー別の区分は？
- 日本の組織診断市場のバリューチェーンにおける様々なステージとは？
- 日本の組織診断の主要な促進要因と課題は何か？
- 日本の組織診断市場の構造と主要企業は？
- 日本の組織診断市場における競合の程度は？
目次
第1章 序文
第2章 調査範囲と調査手法
- 調査の目的
- ステークホルダー
- データソース
- 市場推定
- 調査手法
第3章 エグゼクティブサマリー
第4章 日本の組織診断市場-イントロダクション
- 概要
- 市場力学
- 業界動向
- 競合情報
第5章 日本の組織診断市場情勢
- 過去および現在の市場動向（2019～2024年）
- 市場予測（2025～2033年）
第6章 日本の組織診断市場- 製品タイプ別の内訳
- 機器
- 消耗品
第7章 日本の組織診断市場- 技術別の内訳
- 免疫組織化学
- インサイチューハイブリダイゼーション
- デジタル病理学とワークフロー管理
- 特殊染色
第8章 日本の組織診断市場- 疾患別の内訳
- 乳がん
- 胃がん
- リンパ腫
- 前立腺がん
- 非小細胞肺がん
- その他
第9章 日本の組織診断市場- エンドユーザー別の内訳
- 病院
- 調査室
- 製薬会社
- 契約調査機関
- その他
第10章 日本の組織診断市場- 競合情勢
- 概要
- 市場構造
- 市場企業のポジショニング
- 主要成功戦略
- 競合ダッシュボード
- 企業評価象限
第11章 主要企業のプロファイル
第12章 日本の組織診断市場- 業界分析
- 促進要因・抑制要因・機会
- ポーターのファイブフォース分析
- バリューチェーン分析
第13章 付録
Japan tissue diagnostics market size reached USD 243.6 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 440.4 Million by 2033, exhibiting a growth rate (CAGR) of 6.3% during 2025-2033. The rising advances in technology, such as digital pathology, next-generation sequencing (NGS), and advanced imaging techniques, which have improved the accuracy and efficiency of tissue diagnostics, are driving the market.
Tissue diagnostics is a crucial field in medicine that involves the microscopic examination and analysis of tissue samples to diagnose diseases and provide insights into their underlying causes. It plays a fundamental role in identifying various medical conditions, including cancer, infections, inflammatory disorders, and autoimmune diseases. The process typically begins with the collection of tissue specimens obtained through procedures like biopsies or surgeries. These samples are then processed, embedded in paraffin wax, sliced into thin sections, and stained with specific dyes to enhance visibility under a microscope. Skilled pathologists and histotechnologists examine these stained tissue sections to identify abnormal cellular structures, patterns, and markers. Tissue diagnostics help clinicians make informed decisions about patient treatment plans, including the choice of therapies, surgeries, or medications. Advances in technology, such as immunohistochemistry and molecular testing, have further improved the precision and specificity of tissue diagnostics, enabling personalized medicine approaches. This field continues to evolve, contributing significantly to early disease detection, prognosis prediction, and tailored patient care.
Japan Tissue Diagnostics Market Trends:
The tissue diagnostics market in Japan is experiencing substantial growth, primarily driven by several key factors. Firstly, the increasing prevalence of cancer necessitates advanced diagnostic techniques, fostering a surge in demand for tissue diagnostics. Additionally, the burgeoning geriatric population, who are more susceptible to chronic diseases, further propels this demand. Furthermore, technological advancements in the realm of molecular diagnostics have revolutionized tissue-based testing, rendering it more efficient and accurate. Also, there has been a significant rise in the awareness of personalized medicine among patients and healthcare providers alike. This has led to an increased emphasis on early disease detection and treatment customization, emphasizing the critical role of tissue diagnostics. Moreover, initiatives by government and private organizations to provide funding and grants for research in cancer diagnostics undeniably spur market growth. Apart from this, the continuous evolution in biomarker identification that is bolstering the development of new diagnostic tools is expected to drive the tissue diagnostics market in Japan.
Japan Tissue Diagnostics Market Segmentation: -
Product Type Insights:
- Instruments
- Consumables
Technology Insights:
- Immunohistochemistry
- In Situ Hybridization
- Digital Pathology and Workflow Management
- Special Staining
Disease Insights:
- Breast Cancer
- Gastric Cancer
- Lymphoma
- Prostate Cancer
- Non-Small Cell Lung Cancer
- Others
End User Insights:
- Hospitals
- Research Laboratories
- Pharmaceutical Companies
- Contract Research Organizations
- Others
Competitive Landscape:
The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.
Key Questions Answered in This Report:
- How has the Japan tissue diagnostics market performed so far and how will it perform in the coming years?
- What has been the impact of COVID-19 on the Japan tissue diagnostics market?
- What is the breakup of the Japan tissue diagnostics market on the basis of product type?
- What is the breakup of the Japan tissue diagnostics market on the basis of technology?
- What is the breakup of the Japan tissue diagnostics market on the basis of disease?
- What is the breakup of the Japan tissue diagnostics market on the basis of end user?
- What are the various stages in the value chain of the Japan tissue diagnostics market?
- What are the key driving factors and challenges in the Japan tissue diagnostics?
- What is the structure of the Japan tissue diagnostics market and who are the key players?
- What is the degree of competition in the Japan tissue diagnostics market?
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Japan Tissue Diagnostics Market - Introduction
- 4.1 Overview
- 4.2 Market Dynamics
- 4.3 Industry Trends
- 4.4 Competitive Intelligence
5 Japan Tissue Diagnostics Market Landscape
- 5.1 Historical and Current Market Trends (2019-2024)
- 5.2 Market Forecast (2025-2033)
6 Japan Tissue Diagnostics Market - Breakup by Product Type
- 6.1 Instruments
- 6.1.1 Overview
- 6.1.2 Historical and Current Market Trends (2019-2024)
- 6.1.3 Market Forecast (2025-2033)
- 6.2 Consumables
- 6.2.1 Overview
- 6.2.2 Historical and Current Market Trends (2019-2024)
- 6.2.3 Market Forecast (2025-2033)
7 Japan Tissue Diagnostics Market - Breakup by Technology
- 7.1 Immunohistochemistry
- 7.1.1 Overview
- 7.1.2 Historical and Current Market Trends (2019-2024)
- 7.1.3 Market Forecast (2025-2033)
- 7.2 In Situ Hybridization
- 7.2.1 Overview
- 7.2.2 Historical and Current Market Trends (2019-2024)
- 7.2.3 Market Forecast (2025-2033)
- 7.3 Digital Pathology and Workflow Management
- 7.3.1 Overview
- 7.3.2 Historical and Current Market Trends (2019-2024)
- 7.3.3 Market Forecast (2025-2033)
- 7.4 Special Staining
- 7.4.1 Overview
- 7.4.2 Historical and Current Market Trends (2019-2024)
- 7.4.3 Market Forecast (2025-2033)
8 Japan Tissue Diagnostics Market - Breakup by Disease
- 8.1 Breast Cancer
- 8.1.1 Overview
- 8.1.2 Historical and Current Market Trends (2019-2024)
- 8.1.3 Market Forecast (2025-2033)
- 8.2 Gastric Cancer
- 8.2.1 Overview
- 8.2.2 Historical and Current Market Trends (2019-2024)
- 8.2.3 Market Forecast (2025-2033)
- 8.3 Lymphoma
- 8.3.1 Overview
- 8.3.2 Historical and Current Market Trends (2019-2024)
- 8.3.3 Market Forecast (2025-2033)
- 8.4 Prostate Cancer
- 8.4.1 Overview
- 8.4.2 Historical and Current Market Trends (2019-2024)
- 8.4.3 Market Forecast (2025-2033)
- 8.5 Non-Small Cell Lung Cancer
- 8.5.1 Overview
- 8.5.2 Historical and Current Market Trends (2019-2024)
- 8.5.3 Market Forecast (2025-2033)
- 8.6 Others
- 8.6.1 Historical and Current Market Trends (2019-2024)
- 8.6.2 Market Forecast (2025-2033)
9 Japan Tissue Diagnostics Market - Breakup by End User
- 9.1 Hospitals
- 9.1.1 Overview
- 9.1.2 Historical and Current Market Trends (2019-2024)
- 9.1.3 Market Forecast (2025-2033)
- 9.2 Research Laboratories
- 9.2.1 Overview
- 9.2.2 Historical and Current Market Trends (2019-2024)
- 9.2.3 Market Forecast (2025-2033)
- 9.3 Pharmaceutical Companies
- 9.3.1 Overview
- 9.3.2 Historical and Current Market Trends (2019-2024)
- 9.3.3 Market Forecast (2025-2033)
- 9.4 Contract Research Organizations
- 9.4.1 Overview
- 9.4.2 Historical and Current Market Trends (2019-2024)
- 9.4.3 Market Forecast (2025-2033)
- 9.5 Others
- 9.5.1 Historical and Current Market Trends (2019-2024)
- 9.5.2 Market Forecast (2025-2033)
10 Japan Tissue Diagnostics Market - Competitive Landscape
- 10.1 Overview
- 10.2 Market Structure
- 10.3 Market Player Positioning
- 10.4 Top Winning Strategies
- 10.5 Competitive Dashboard
- 10.6 Company Evaluation Quadrant
11 Profiles of Key Players
- 11.1 Company A
- 11.1.1 Business Overview
- 11.1.2 Product Portfolio
- 11.1.3 Business Strategies
- 11.1.4 SWOT Analysis
- 11.1.5 Major News and Events
- 11.2 Company B
- 11.2.1 Business Overview
- 11.2.2 Product Portfolio
- 11.2.3 Business Strategies
- 11.2.4 SWOT Analysis
- 11.2.5 Major News and Events
- 11.3 Company C
- 11.3.1 Business Overview
- 11.3.2 Product Portfolio
- 11.3.3 Business Strategies
- 11.3.4 SWOT Analysis
- 11.3.5 Major News and Events
- 11.4 Company D
- 11.4.1 Business Overview
- 11.4.2 Product Portfolio
- 11.4.3 Business Strategies
- 11.4.4 SWOT Analysis
- 11.4.5 Major News and Events
- 11.5 Company E
- 11.5.1 Business Overview
- 11.5.2 Product Portfolio
- 11.5.3 Business Strategies
- 11.5.4 SWOT Analysis
- 11.5.5 Major News and Events
12 Japan Tissue Diagnostics Market - Industry Analysis
- 12.1 Drivers, Restraints, and Opportunities
- 12.1.1 Overview
- 12.1.2 Drivers
- 12.1.3 Restraints
- 12.1.4 Opportunities
- 12.2 Porters Five Forces Analysis
- 12.2.1 Overview
- 12.2.2 Bargaining Power of Buyers
- 12.2.3 Bargaining Power of Suppliers
- 12.2.4 Degree of Competition
- 12.2.5 Threat of New Entrants
- 12.2.6 Threat of Substitutes
- 12.3 Value Chain Analysis
